FDA Adverse Event Injury Summary report: N

DUROM US ACETABAR COMPONENT 52/46 L

MDR report key: 1780939 · Received July 21, 2010

Report

Report Number
9613350-2010-00360
Event Type
Injury
Date Received
July 21, 2010
Date of Event
June 13, 2010
Report Date
July 7, 2010
Manufacturer
ZIMMER GMBH
Product Code
KWA
Removal / Correction Number
9613350-07/15/2008-001
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INFORMATION WAS FORWARDED FROM THE OWNER ESTABLISHMENT, ZIMMER INC., WHICH MARKETS THE DEVICES IN THE U.S. THE MANUFACTURER DID NOT RECEIVE EXPLANTED DEVICES, X-RAYS, OR OTHER SOURCE DOCUMENTS FOR REVIEW. WHERE LOT NUMBERS WERE RECEIVED FOR THE EXPLANTED DEVICES, THE DEVICE HISTORY RECORDS WERE REVIEWED AND FOUND TO BE CONFORMING. WHILE A CAUSE FOR THIS SPECIFIC CLINICAL EVENT CANNOT BE ASCERTAINED FROM THE INFORMATION PROVIDED, THE COMMON CLINICAL PRESENTATION AND THE DATE OF THE ORIGINAL IMPLANTATION SUGGEST THAT THE REVISION SURGERY IS RELATED TO THE ISSUES FOR WHICH ZIMMER IMPLEMENTED A CORRECTION IN JULY 2008. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE AND / OR THE DEVICE(S) BE RETURNED FOR EVALUATION AND AN INVESTIGATION RESULT BE AVAILABLE, THAT CHANGES THIS ASSESSMENT, AN AMENDED MEDICAL DEVICE REPORT WILL BE FILED. THE NEED FOR FURTHER CORRECTIVE MEASURES IS NOT INDICATED AT THIS TIME AND ZIMMER (B)(4) CONSIDERS THIS CASE CLOSED. (B)(4).

Description of Event or Problem · 1

IT IS REPORTED THAT PATIENT HAD TO UNDERGO A REVISION SURGERY DUE TO IMPLANT LOOSENING (ACETABULAR COMPONENT).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DUROM US ACETABAR COMPONENT 52/46 L DUROM ACETABULAR COMPONENT AND METASUL KWA ZIMMER GMBH NA 2406912

Patients

Seq Age Sex Outcome Treatment
1 79 YR Hospitalization| R